Bronchodilators, corticosteroids, muscarinic antagonists, methylxanthines, phosphodiesterase-4 (PDE4) inhibitors, and mucolytic agents currently constitute the treatment for COPD [3]. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.